Clinical Services Rise to No. 3 in Nation
Our Division climbed from fourth to third in the nation among all pediatric urology programs ranked by US News and World Report. The division’s national reputation is linked to institutional and divisional strategic goals for clinical expansion. The Center for Disorders of Sex Development (DSD) has provided world-class specialized care for children with congenital chromosomal, gonadal or anatomical variations of sex development. Our Urogenital Center cares for children with highly complex genitourinary conditions involving abnormalities of the bladder, urethra, vagina and anorectum. A third multidisciplinary center, the Stone Center was established offering comprehensive, cost effective and coordinated care management of patients with stone disease of the urinary system. We participated in Cincinnati Children’s phase one Care Coordination cohort. Our team also has established reporting systems and outcome measures for renal function, social continence, and self-management for patients with Posterior Urethral Valves (PUV).
Surgeons Share Expertise Overseas
Partnering with Global Health, Pramod Reddy, MD traveled to India and Eugene Minevich, MD, traveled to Israel to perform complex urological surgeries. Several faculty members also were invited to present at international pediatric urology conferences: W. Robert DeFoor, Jr., MD, MPH, in England; Minevich in England and Italy; Reddy in India, United Arab Emirates and Hungary; and Paul Noh, MD, in South Korea.
Leading Basic and Clinical Research
Reddy’s lab has focused on using a mouse model to study changes in bladder function and morphology induced by social stress. Reddy also leads a clinical trial to evaluate fesoterodine as a treatment for neurogenic detrusor overactivity.
Joo-Seop Park, PhD, is investigating the self-renewal and differentiation of nephron progenitors during nephrogenesis. Park also attained Trustee Award Funding and a Research Innovation Pilot Funding Award.
DeFoor is the principal investigator on a subcontract for the NIH clinical trial, “Randomized intervention for children with vesicoureteral reflux (RIVUR).” DeFoor and Minevich are evaluating Deflux for VUR patients receiving endoscopic correction. DeFoor also is in a clinical trial using Botox in the treatment of urinary incontinence.
Elizabeth Jackson, MD, is studying, “Nocturnal Enuresis: Comparison of Buzzer and Voice Alarms on the Rate of Resolution of Bedwetting.”